DuPont(US:DD)2025-11-06 18:36Financial Performance - Net sales for Q3 2025 reached $3,072 million, a 7.3% increase from $2,862 million in Q3 2024[20] - The net loss attributable to DuPont common stockholders for Q3 2025 was $123 million, compared to a net income of $455 million in Q3 2024[20] - Comprehensive loss income for Q3 2025 was $185 million, a significant decrease from a comprehensive income of $859 million in Q3 2024[22] - The company reported a net income from continuing operations of $747 million for the nine months ended September 30, 2025, slightly down from $753 million in 2024[26] - For the three months ended September 30, 2025, net income attributable to common stockholders was $(123) million, compared to $455 million in 2024, representing a decrease of 127%[9] - Earnings per share (EPS) from continuing operations for the three months ended September 30, 2025, was $0.70, down from $1.06 in 2024, a decline of 34%[9] Assets and Liabilities - Total assets as of September 30, 2025, were $38,044 million, an increase from $36,636 million at the end of 2024[24] - Long-term debt rose to $7,049 million as of September 30, 2025, compared to $5,323 million at the end of 2024, indicating a 32.5% increase[24] - DuPont's total liabilities increased to $14,703 million as of September 30, 2025, compared to $12,843 million at the end of 2024[24] - The company’s cash and cash equivalents at the end of Q3 2025 were $3,826 million, up from $1,686 million at the end of Q3 2024[26] - The company’s total assets of discontinued operations were valued at $1.813 billion as of September 30, 2025, down from $3.003 billion at December 31, 2024[60] Acquisitions and Divestitures - DuPont completed the acquisition of Donatelle Plastics for a net purchase price of $365 million, which includes a contingent earn-out liability of $40 million[48] - DuPont signed an agreement to acquire Sinochem for $56 million, with the transaction closing on October 10, 2025[46] - DuPont announced the Aramids Divestiture for a gross consideration of $1.8 billion, expecting to receive approximately $1.2 billion in cash proceeds, a $300 million interest-bearing note, and a $325 million equity interest, with the transaction expected to close in Q1 2026[56] - The Aramids Divestiture resulted in a net loss from discontinued operations of $372 million for Q3 2025 and $1,118 million for the nine months ended September 30, 2025[63] Research and Development - Research and development expenses increased to $140 million in Q3 2025, up from $127 million in Q3 2024, reflecting a 10.2% rise[20] Cash Flow and Operating Activities - Cash provided by operating activities from continuing operations for the nine months ended September 30, 2025, was $1,260 million, down from $1,517 million in the same period of 2024[26] - The company recorded $139 million in acquisition, integration, and separation costs for Q3 2025, compared to $43 million in Q3 2024, primarily related to the Electronics Separation[67] Restructuring and Charges - Restructuring charges for the three months ended September 30, 2025, were $20 million, compared to $21 million for the same period in 2024, while for the nine months ended September 30, 2025, charges were $67 million, up from $56 million in 2024[77] - The 2023-2024 Restructuring Program recorded pre-tax restructuring charges of $174 million, including $101 million in severance and related benefits and $73 million in asset-related charges[80] Environmental and Legal Matters - The company has accrued obligations of $265 million for probable environmental remediation and restoration costs[164] - DuPont's contribution to the Water District Settlement Fund was $400 million, part of a total settlement of $1.185 billion for PFAS-related claims[142][143] - As of September 30, 2025, there are approximately 10,000 personal injury cases filed in the AFFF MDL, with many cases including multiple plaintiffs[148] Shareholder Returns - The company declared dividends of $1.23 per common share, totaling $515 million[31] - The company repurchased a total of 27.9 million shares at an average price of $71.67 per share under the $2 billion accelerated share repurchase transaction[173] Tax and Interest - The effective tax rate on continuing operations for Q3 2025 was 5.8%, significantly lower than 17.9% for Q3 2024, primarily due to the release of a valuation allowance[94] - Interest income for the three months ended September 30, 2025, was $27 million, compared to $14 million for the same period in 2024[84]